Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy

[1]  P. Lambiase,et al.  2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. , 2022, European heart journal.

[2]  Christopher A. Miller,et al.  Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy. , 2022, European heart journal. Cardiovascular Imaging.

[3]  P. Banys,et al.  Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy , 2021, Scientific Reports.

[4]  A. Arai,et al.  T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study. , 2021, JACC. Cardiovascular imaging.

[5]  Christopher A. Miller,et al.  Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy. , 2021, Journal of the American College of Cardiology.

[6]  S. Rapacchi,et al.  Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference. , 2020, Diagnostic and interventional imaging.

[7]  A. Coats,et al.  Heart failure in dilated non-ischaemic cardiomyopathy , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[8]  M. Dweck,et al.  Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis , 2019, JACC. Cardiovascular imaging.

[9]  Reza Nezafat,et al.  Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2018, Journal of Cardiovascular Magnetic Resonance.

[10]  Sven Kabus,et al.  Cardiac magnetic resonance T1 and extracellular volume mapping with motion correction and co-registration based on fast elastic image registration , 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.

[11]  H. Lee,et al.  Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study , 2017, European Radiology.

[12]  C. Colak,et al.  The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI , 2017, La radiologia medica.

[13]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[14]  V. Fuster,et al.  The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.

[15]  P. Kellman,et al.  T1-mapping in the heart: accuracy and precision , 2014, Journal of Cardiovascular Magnetic Resonance.

[16]  W. Stevenson,et al.  CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[17]  D. Hedges,et al.  Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.

[18]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[19]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[20]  Michael Jerosch-Herold,et al.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[22]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[23]  James A. White,et al.  Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.

[24]  E. Nagel,et al.  T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.

[25]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..